Clinical Study of Intratumoral Injection of CAR-T Cells in the Treatment of Advanced Liver Tumors
Condition: Hepatocellular Carcinoma , Cholangiocarcinoma Intervention: Biological: anti-GPC3 CAR-T cells Sponsor: Beijing Immunochina Medical Science& Technology Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bile Duct Cancer | Biomedical Science | Cancer & Oncology | Carcinoma | Cholangiocarcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Research | Science | Study | Urology & Nephrology